REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA

Clinical trials for REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill targets tough cancers in early safety trial

Disease control Recruiting now

This is a first-in-human study to find a safe dose of a new oral drug called IACS-6274. It will be tested alone and in two different drug combinations in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the safety …

Matched conditions: REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA

Get alerted when new REFRACTORY OVARIAN CLEAR CELL ADENOCARCINOMA trials appear

New pill targets tough cancers in early safety trial